PATIENT PURE X - PPX Trademark

Trademark Overview

On Friday, January 24, 2020, a trademark application was filed for PATIENT PURE X - PPX with the United States Patent and Trademark Office. The USPTO has given the PATIENT PURE X - PPX trademark a serial number of 88771931. The federal status of this trademark filing is REGISTERED as of Tuesday, February 22, 2022. This trademark is owned by Organicell Regenerative Medicine, Inc.. The PATIENT PURE X - PPX trademark is filed in the Pharmaceutical Products category with the following description:

plasma extracts for medical use, namely, plasma extract containing purified and concentrated exosomes derived from whole human blood
patient pure x - ppx

General Information

Serial Number88771931
Word MarkPATIENT PURE X - PPX
Filing DateFriday, January 24, 2020
Status700 - REGISTERED
Status DateTuesday, February 22, 2022
Registration Number6654296
Registration DateTuesday, February 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Goods and Servicesplasma extracts for medical use, namely, plasma extract containing purified and concentrated exosomes derived from whole human blood
Pseudo MarkPATIENT PURE X - PATIENT PURE X
Disclaimer with Predetermined Text"PATIENT PURE X"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 28, 2020
Primary Code005
First Use Anywhere DateFriday, August 13, 2021
First Use In Commerce DateFriday, August 13, 2021

Trademark Owner History

Party NameOrganicell Regenerative Medicine, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFt. Lauderdale, FL 33328
Party NameOrganicell Regenerative Medicine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiami, FL 33136
Party NameOrganicell Regenerative Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33136

Trademark Events

Event DateEvent Description
Tuesday, February 27, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 27, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 27, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 14, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, November 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 22, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, January 20, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 19, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, January 9, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, December 17, 2021USE AMENDMENT FILED
Sunday, January 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 17, 2021TEAS STATEMENT OF USE RECEIVED
Friday, July 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 28, 2021SOU EXTENSION 2 GRANTED
Wednesday, July 28, 2021SOU EXTENSION 2 FILED
Wednesday, July 28, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, January 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 25, 2021SOU EXTENSION 1 GRANTED
Monday, January 25, 2021SOU EXTENSION 1 FILED
Monday, January 25, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020ASSIGNED TO LIE
Tuesday, April 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 21, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, April 21, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 21, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, April 21, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 14, 2020ASSIGNED TO EXAMINER
Tuesday, January 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 28, 2020NEW APPLICATION ENTERED

Related Keywords

pure patient plasma derived from whole blood human exosomes purified medical extracts